In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cesca Therapeutics Inc. (NASDAQ:KOOL) reported that Haefling Carl. has picked up 454,400 of common stock as of 2017-02-09.
The acquisition brings the aggregate amount owned by Haefling Carl. to a total of 454,400 representing a 4.6% stake in the company.
For those not familiar with the company, Cesca Therapeutics Inc. is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. The Company focuses on the business of research, development and commercialization of autologous cell-based therapeutics for use in the regenerative medicine industry. The Company’s therapeutic development initiatives focuses on the fields of cardiovascular medicine and orthopedic regeneration. The Company offers a range of products, such as SurgWerks System, CellWerks System, AutoXpress System (AXP), MarrowXpress System (MXP), BioArchive System, and manual bag sets for use in the processing and cryogenic storage of cord blood.
A glance at Cesca Therapeutics Inc. (NASDAQ:KOOL)’s key stats reveals a current market capitalization of 28.53 million based on 9.79 million shares outstanding and a price at last close of $2.93 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-26, Boyalife picked up 6,102,942 at a purchase price of $2.52. This brings their total holding to 6,838,237 as of the date of the filing.
On the sell side, the most recent transaction saw Harris unload 2,200 shares at a sale price of $0.60. This brings their total holding to 4,490,410.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cesca Therapeutics Inc. (NASDAQ:KOOL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
